| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:736733 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PCCA mRNA | CTD | PMID:22079256 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:736733 | 6480464 | Ethinyl Estradiol results in increased expression of PCCA mRNA | CTD | PMID:18936297 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PCCA mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | ISO | | 6480464 | Ethinyl Estradiol results in increased expression of PCCA mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:733831 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PCCA mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:733831 | 6480464 | Ethinyl Estradiol results in increased expression of PCCA mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:733831 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PCCA mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PCCA mRNA | CTD | PMID:17942748 |
| 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of PCCA mRNA | CTD | PMID:21346803 |
| 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of PCCA mRNA | CTD | PMID:21346803 |
| 2-methylcholine | affects expression | ISO | RGD:736733 | 6480464 | beta-methylcholine affects the expression of PCCA mRNA | CTD | PMID:21179406 |
| aflatoxin B1 | decreases expression | ISO | RGD:733831 | 6480464 | Aflatoxin B1 results in decreased expression of PCCA mRNA | CTD | PMID:19770486 |
| aflatoxin B1 | decreases expression | ISO | | 6480464 | Aflatoxin B1 results in decreased expression of PCCA mRNA | CTD | PMID:19770486 |
| aflatoxin B1 | decreases expression | ISO | RGD:736733 | 6480464 | Aflatoxin B1 results in decreased expression of PCCA mRNA | CTD | PMID:22100608 |
| aflatoxin B1 | affects expression | ISO | RGD:736733 | 6480464 | Aflatoxin B1 affects the expression of PCCA protein | CTD | PMID:20106945 |
| benzo[a]pyrene | decreases expression | ISO | RGD:736733 | 6480464 | Benzo(a)pyrene results in decreased expression of PCCA mRNA | CTD | PMID:20106945 PMID:20064835 |
| benzo[a]pyrene | increases expression | ISO | | 6480464 | Benzo(a)pyrene results in increased expression of PCCA mRNA | CTD | PMID:22228805 |
| benzo[a]pyrene | decreases expression | ISO | | 6480464 | Benzo(a)pyrene results in decreased expression of PCCA mRNA | CTD | PMID:19770486 more ... |
| benzo[a]pyrene | multiple interactions | ISO | | 6480464 | AHR protein affects the reaction [Benzo(a)pyrene affects the expression of PCCA mRNA] | CTD | PMID:22228805 |
| benzo[a]pyrene | decreases expression | ISO | RGD:733831 | 6480464 | Benzo(a)pyrene results in decreased expression of PCCA mRNA | CTD | PMID:21715664 more ... |
| benzo[a]pyrene | decreases expression | ISO | RGD:736733 | 6480464 | Benzo(a)pyrene results in decreased expression of PCCA mRNA | CTD | PMID:20064835 PMID:20106945 |
| benzo[a]pyrene | decreases expression | ISO | RGD:733831 | 6480464 | Benzo(a)pyrene results in decreased expression of PCCA mRNA | CTD | PMID:20713471 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:733831 | 6480464 | Benzo(a)pyrene results in increased expression of PCCA mRNA | CTD | PMID:22228805 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:733831 | 6480464 | AHR protein affects the reaction [Benzo(a)pyrene affects the expression of PCCA mRNA] | CTD | PMID:22228805 |
| benzo[a]pyrene | decreases expression | ISO | RGD:733831 | 6480464 | Benzo(a)pyrene results in decreased expression of PCCA mRNA | CTD | PMID:19770486 more ... |
| benzo[a]pyrene | decreases expression | ISO | RGD:736733 | 6480464 | Benzo(a)pyrene results in decreased expression of PCCA mRNA | CTD | PMID:20064835 more ... |
| benzo[a]pyrene | decreases expression | ISO | RGD:733831 | 6480464 | Benzo(a)pyrene results in decreased expression of PCCA mRNA | CTD | PMID:19770486 more ... |
| choline | multiple interactions | ISO | RGD:733831 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PCCA mRNA | CTD | PMID:20938992 |
| choline | multiple interactions | ISO | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PCCA mRNA | CTD | PMID:20938992 |
| cyclosporin A | decreases expression | ISO | RGD:736733 | 6480464 | Cyclosporine results in decreased expression of PCCA mRNA | CTD | PMID:20106945 |
| Delta(9)-tetrahydrocannabinol | increases expression | EXP | | 6480464 | Tetrahydrocannabinol results in increased expression of PCCA mRNA | CTD | PMID:16616335 |
| diarsenic trioxide | increases expression | ISO | RGD:736733 | 6480464 | arsenic trioxide results in increased expression of PCCA mRNA | CTD | PMID:22521957 |
| dibutyl phthalate | decreases expression | ISO | RGD:733831 | 6480464 | Dibutyl Phthalate results in decreased expression of PCCA mRNA | CTD | PMID:17361019 PMID:21266533 |
| dibutyl phthalate | decreases expression | ISO | | 6480464 | Dibutyl Phthalate results in decreased expression of PCCA mRNA | CTD | PMID:17361019 PMID:21266533 |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of PCCA mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | decreases expression | ISO | RGD:733831 | 6480464 | Dibutyl Phthalate results in decreased expression of PCCA mRNA | CTD | PMID:21266533 |
| diuron | decreases expression | EXP | | 6480464 | Diuron results in decreased expression of PCCA mRNA | CTD | PMID:21551480 |
| folic acid | multiple interactions | ISO | RGD:733831 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PCCA mRNA | CTD | PMID:20938992 |
| folic acid | multiple interactions | ISO | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PCCA mRNA | CTD | PMID:20938992 |
| L-methionine | multiple interactions | ISO | RGD:733831 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PCCA mRNA | CTD | PMID:20938992 |
| L-methionine | multiple interactions | ISO | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PCCA mRNA | CTD | PMID:20938992 |
| menadione | affects expression | ISO | RGD:736733 | 6480464 | Vitamin K 3 affects the expression of PCCA mRNA | CTD | PMID:20044591 |
| paclitaxel | decreases expression | ISO | RGD:736733 | 6480464 | Paclitaxel results in decreased expression of PCCA protein | CTD | PMID:15907983 |
| paracetamol | affects expression | ISO | RGD:733831 | 6480464 | Acetaminophen affects the expression of PCCA mRNA | CTD | PMID:17562736 |
| paracetamol | increases expression | ISO | | 6480464 | Acetaminophen results in increased expression of PCCA protein | CTD | PMID:21329376 |
| paracetamol | affects expression | ISO | | 6480464 | Acetaminophen affects the expression of PCCA mRNA | CTD | PMID:17562736 |
| paracetamol | increases expression | ISO | RGD:733831 | 6480464 | Acetaminophen results in increased expression of PCCA protein | CTD | PMID:21329376 |
| phlorizin | decreases expression | ISO | RGD:733831 | 6480464 | Phlorhizin results in decreased expression of PCCA mRNA | CTD | PMID:22538082 |
| phlorizin | decreases expression | ISO | | 6480464 | Phlorhizin results in decreased expression of PCCA mRNA | CTD | PMID:22538082 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of PCCA mRNA | CTD | PMID:19162173 |
| quercetin | decreases expression | ISO | RGD:736733 | 6480464 | Quercetin results in decreased expression of PCCA mRNA | CTD | PMID:21632981 |
| sodium dichromate | affects expression | EXP | | 6480464 | sodium bichromate affects the expression of PCCA mRNA | CTD | PMID:22110744 |
| tunicamycin | decreases expression | ISO | RGD:733831 | 6480464 | Tunicamycin results in decreased expression of PCCA mRNA | CTD | PMID:17127020 |
| tunicamycin | decreases expression | ISO | | 6480464 | Tunicamycin results in decreased expression of PCCA mRNA | CTD | PMID:17127020 |
| vancomycin | increases expression | ISO | RGD:733831 | 6480464 | Vancomycin results in increased expression of PCCA mRNA | CTD | PMID:18930951 |
| vancomycin | increases expression | ISO | | 6480464 | Vancomycin results in increased expression of PCCA mRNA | CTD | PMID:18930951 |